Needham & Company
View Older Stories
-
Perrigo Announces Closing of Prevacid®24HR (OTC) Acquisition, Advancing Consumer Self-Care Growth Strategy
-
Form 4 PERRIGO Co plc For: Oct 08 Filed by: Needham Jeffrey
-
Perrigo Announces First Quarter Calendar Year 2019 Earnings Date And Upcoming Conference Participation
-
Form 4 PERRIGO Co plc For: Mar 06 Filed by: Needham Jeffrey
-
Form 4 PERRIGO Co plc For: Feb 26 Filed by: Needham Jeffrey
-
Form 4 PERRIGO Co plc For: Oct 08 Filed by: Needham Jeffrey
-
Perrigo (PRGO) Reports Final FDA Approval for Store Brand OTC Equivalent of Imodium Multi-Symptom Relief
-
Perrigo Announces Final FDA Approval and Planned Launch for the Store Brand OTC Equivalent of Imodium® Multi-Symptom Relief
-
Perrigo Expands OTC Growth Strategy With Rx-To-OTC Switch Licensing For Nasonex®
-
Form 4 PERRIGO Co plc For: Jun 29 Filed by: Needham Jeffrey
-
Form 4 PERRIGO Co plc For: Apr 02 Filed by: Needham Jeffrey
-
Perrigo Launches Novel Omeprazole Orally Disintegrating Tablet to Treat Frequent Heartburn
-
Form 4 PERRIGO Co plc For: Mar 08 Filed by: Needham Jeffrey
-
Perrigo (PRGO) Announces Final FDA Approval, Planned Launch for Store Brand OTC Equivalent of Mucinex DM Maximum Strength ER Tablets
-
Perrigo Announces Final FDA Approval and Planned Launch for the Store Brand OTC Equivalent of Mucinex® DM Maximum Strength Extended Release Tablets
-
Perrigo (PRGO) Announces First-To-Market Launch of OTC Store Brand Equivalent of Nexium 24HR Capsules
-
Perrigo Announces First-To-Market Launch Of The OTC Store Brand Equivalent Of Nexium® 24HR Capsules
-
Form 4 PERRIGO Co plc For: Sep 12 Filed by: Needham Jeffrey
-
Form 4 PERRIGO Co plc For: Aug 21 Filed by: Needham Jeffrey
-
Perrigo (PRGO) Announces Final FDA Approval, Settlement for Store Brand OTC Equivalent Of Nexium 24HR Capsules
-
Perrigo Announces Final FDA Approval And Settlement For The Store Brand OTC Equivalent Of Nexium® 24HR Capsules
-
Perrigo Company To Present At The 17th Annual Oppenheimer Consumer Conference
-
Form 4 PERRIGO Co plc For: Jun 06 Filed by: Needham Jeffrey
-
Form 4 PERRIGO Co plc For: May 31 Filed by: Needham Jeffrey
-
Form 4/A PERRIGO Co plc For: May 14 Filed by: Needham Jeffrey
-
Pre-Open Movers 02/07: (PRCP) (AVXL) (ATHX) Higher; (FXCM) (KTOV) (KORS) Lower (more...)
-
Perrigo (PRGO) Gains FDA Approval for Generic Nicorette White Ice Mint Gum
-
Perrigo Announces FDA Approvals For The Store Brand OTC Equivalents To Nicorette® White Ice Mint® Gum
-
Perrigo (PRGO) Enters Licensing Agreement with Highland Pharma for Tarex Technology
-
Perrigo Invests In Tarex® Patented Technology, As A Key Investment In The Fight Against Methamphetamine Drug Abuse
-
Form 4 PERRIGO Co plc For: Aug 22 Filed by: Needham Jeffrey
-
Form 4 PERRIGO Co plc For: Aug 19 Filed by: Needham Jeffrey
-
Form 4 PERRIGO Co plc For: Feb 26 Filed by: Needham Jeffrey
-
Global Health Care Supplier Perrigo Adopts Digimarc Barcode for Enhanced Consumer Information and Retailer Point-of-Sale Efficiency
-
Form 4 PERRIGO Co plc For: Aug 21 Filed by: Needham Jeffrey
-
Pre-Open Stock Movers 07/27: (MAG) (TEVA) (AGN) Higher; (BLPH) (MYL) (GRUB) Lower (more...)
-
Form 4 PERRIGO Co plc For: Jun 29 Filed by: Needham Jeffrey
-
Form 4 PERRIGO Co plc For: May 14 Filed by: Needham Jeffrey
-
Streetinsider.com's Hot Lunchtime Reads 5/7: (SZYM) (PRGO) (CLI) (ZU) (SRPT)
-
Form 4 PERRIGO Co plc For: Aug 26 Filed by: Needham Jeffrey
-
Form 4 PERRIGO Co plc For: Aug 22 Filed by: Needham Jeffrey
-
Form 4 PERRIGO Co plc For: Aug 21 Filed by: Needham Jeffrey
-
Pre-Open Stock Movers 8/14 (OVTI) (PLUG) (KBIO) Higher; (RRGB) (NDLS) (XONE) Lower (more...)
-
Notable Analyst Rating Changes 02/04: (BBRY) (BRO) (WU) Upgraded; (BUD) (WMT) (VOD) Downgraded
-
Needham & Company Raises Estimates on Perrigo Co. (PRGO); Another Winning Quarter; Demanding Valuation
-
Needham & Company Maintains a 'Hold' on Perrigo Co. (PRGO); Disappoints on Top-line Expectations
-
Needham & Company maintains a 'Hold' on Perrigo Co. (PRGO); Q2 Outpaces Despite Some Segmental Head Winds
-
Needham & Company Maintains a 'Hold' on Perrigo Co. (PRGO); Fundamentals Remain Strong Though Valuation Embeds Execution Perfection
-
Needham & Company Maintains a 'Hold' on Perrigo Co. (PRGO); Initial Outlook Fails to Surpass Initial Street Estimates Though the Beat & Raise Trade Alive
-
Needham & Company maintains a 'Hold' on Perrigo Co. (PRGO); TEVA Comes Through With Allegra OTC Approval, “In Numbers” but Should Provide Additional Fuel

